Gender-, strain-, and inheritance-dependent variation in aldosterone secretion in mice

Journal of Endocrinology

Volumn 215, Issue 3, 2012, Pages 375-381

  Spyroglou, Ariadni ^a   Sabrautzki, Sibylle ^b   Rathkolb, Birgit ^b   Bozoglu, Tarik ^a   De Angelis, Martin Hrabé ^b,c   Reincke, Martin ^a   Bidlingmaier, Martin ^a   Beuschlein, Felix ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); POTASSIUM; RENIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ALDOSTERONE RELEASE; ANIMAL EXPERIMENT; ARTICLE; FEMALE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHERITANCE; KIDNEY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; STEROIDOGENESIS;

ALDOSTERONE; ANIMALS; FEMALE; MALE; MICE; MICE, INBRED C57BL; POTASSIUM; REAL-TIME POLYMERASE CHAIN REACTION; RENIN; SEX FACTORS;

EID: 84872176672     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0429     Document Type: Article

References (27)

1. Alvarez-Madrazo S, Padmanabhan S, Mayosi BM, Watkins H, Avery P, Wallace AM, Fraser R, Davies E, Keavney B & Connell JM 2009 Familial and phenotypic associations of the aldosterone renin ratio. Journal of Clinical Endocrinology and Metabolism 94 4324-4333. (doi:10.1210/jc.2009-1406)
2. Beuschlein F & Reincke M 2007 Therapy-resistant hypertension - the endocrinological view. MMW Fortschritte der Medizin 149 29-32.
3. Boulkroun S, Beuschlein F, Rossi GP, Golib-Dzib JF, Fischer E, Amar L, Mulatero P, Samson-Couterie B, Hahner S, Quinkler M et al. 2012 Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 59 592-598. (doi:10.1161/HYPERTENSIONAHA. 111.186478)
4. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, HigginsM, Horan MJ & Labarthe D 1995 Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25 305-313. (doi:10.1161/01.HYP.25. 3.305)
5. Choi M, Scholl UI, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ et al. 2011 KC channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331 768-772. (doi:10.1126/science.1198785)
6. Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, Carey RM, Bayliss DA & Barrett PQ 2008 TASK channel deletion in mice causes primary hyperaldosteronism. PNAS 105 2203-2208. (doi:10.1073/pnas. 0712000105)
7. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A et al. 2000 Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. Journal of Clinical Endocrinology and Metabolism 85 1863-1867. (doi:10.1210/jc.85.5.1863)
8. Giacche M, Vuagnat A, Hunt SC, Hopkins PN, Fisher ND, Azizi M, Corvol P, Williams GH & Jeunemaitre X 2000 Aldosterone stimulation by angiotensin II: influence of gender, plasma renin, and familial resemblance. Hypertension 35 710-716. (doi:10.1161/01.HYP.35.3.710)
9. Hampf M, Dao NT, Hoan NT & Bernhardt R 2001 Unequal crossing-over between aldosterone synthase and 11b-hydroxylase genes causes congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 86 4445-4452. (doi:10.1210/jc.86.9.4445)
10. Hannemann A, Bidlingmaier M, Friedrich N, Manolopoulou J, Spyroglou A, Volzke H, Beuschlein F, Seissler J, Rettig R, Felix SB et al. 2012 Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. European Journal of Endocrinology 167 7-15. (doi:10.1530/EJE-11-1013)
11. Heitzmann D, Derand R, Jungbauer S, Bandulik S, Sterner C, Schweda F, El Wakil A, Lalli E, Guy N, Mengual R et al. 2008 Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO Journal 27 179-187. (doi:10.1038/sj.emboj.7601934)
12. Iida A, Blake K, Tunny T, Klemm S, Stowasser M, Hayward N, Gordon R, Nakamura Y & Imai T 1995 Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors. Genes, Chromosomes & Cancer 12 73-75. (doi:10.1002/gcc.2870120114)
13. James GD, Sealey JE, Muller F, Alderman M, Madhavan S & Laragh JH 1986 Renin relationship to sex, race and age in a normotensive population. Journal of Hypertension. Supplement 4 S387-S389. (doi:10.1097/00004872- 198608000-00001)
14. Kawamoto T, Mitsuuchi Y, Toda K, Miyahara K, Yokoyama Y, Nakao K, Hosoda K, Yamamoto Y, Imura H & Shizuta Y 1990 Cloning of cDNA and genomic DNA for human cytochrome P-45011 b. FEBS Letters 269 345-349. (doi:10.1016/0014-5793(90)81190-Y)
15. Manolopoulou J, Bielohuby M, Caton SJ, Gomez-Sanchez CE, Renner-Mueller I, Wolf E, Lichtenauer UD, Beuschlein F, Hoeflich A & Bidlingmaier M 2008 A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: validation in mouse serum. Journal of Endocrinology 196 215-224. (doi:10.1677/JOE-07-0134)
16. Mattson DL 2001 Comparison of arterial blood pressure in different strains of mice. American Journal of Hypertension 14 405-408. (doi:10.1016/S0895- 7061(00)01285-1)
17. Miller JA, Anacta LA & Cattran DC 1999 Impact of gender on the renal response to angiotensin II. Kidney International 55 278-285. (doi:10.1046/j. 1523-1755.1999.00260.x)
18. Morganti A, Turolo L, Pulazzini E & Zanchetti A 1987 Comparative measurements of immunoreactive renin, plasma renin activity and angiotensin II in human plasma. Clinical and Experimental Hypertension. Part A, Theory and Practice 9 1367-1381. (doi:10.3109/10641968709158990)
19. Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ, Kathiresan S, O'Donnell CJ, Musone SL, Camargo AL et al. 2007 Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 49 846-856. (doi:10.1161/ 01.HYP.0000258554.87444.91)
20. Reckelhoff JF 2001 Gender differences in the regulation of blood pressure. Hypertension 37 1199-1208. (doi:10.1161/01.HYP.37.5.1199)
21. Roesch DM, Tian Y, Zheng W, Shi M, Verbalis JG & Sandberg K 2000 Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats. Endocrinology 141 4629-4636. (doi:10.1210/en.141. 12.4629)
22. Russo P, Siani A, Venezia A, Iacone R, Russo O, Barba G, D'Elia L, Cappuccio FP & Strazzullo P 2002 Interaction between the C(K344)T polymorphism of CYP11B2 and age in the regulation of blood pressure and plasma aldosterone levels: cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. Journal of Hypertension 20 1785-1792. (doi:10.1097/00004872-200209000-00023)
23. Schirpenbach C & Reincke M 2007 Primary aldosteronism: current knowledge and controversies in Conn's syndrome. Nature Clinical Practice. Endocrinology & Metabolism 3 220-227. (doi:10.1038/ncpendmet0430)
24. Singer JB, Hill AE, Burrage LC, Olszens KR, Song J, Justice M, O'Brien WE, Conti DV, Witte JS, Lander ES et al. 2004 Genetic dissection of complex traits with chromosome substitution strains of mice. Science 304 445-448. (doi:10.1126/science.1093139)
25. Spyroglou A, Manolopoulou J, Wagner S, Bidlingmaier M, Reincke M & Beuschlein F 2009 Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice. Journal of Molecular Endocrinology 42 407-413. (doi:10.1677/JME-08-0167)
26. Spyroglou A, Wagner S, Gomez-Sanchez C, Rathkolb B, Wolf E, Manolopoulou J, Reincke M, Bidlingmaier M, Hrabe de Angelis M & Beuschlein F 2010 Utilization of a mutagenesis screen to generate mouse models of hyperaldosteronism. Endocrinology 152 326-331. (doi:10.1210/ en.2010-1081)
27. Sun M, Manolopoulou J, Spyroglou A, Beuschlein F, Hantel C, Wu Z, Bielohuby M, Hoeflich A, Liu C & Bidlingmaier M 2010 A microspherebased duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: validation in human and mouse plasma. Steroids 75 1089-1096. (doi:10.1016/j.steroids. 2010.07.005)